Objective: We evaluated if epidemiological features of familial prostate cancer are
associated with certain clinical or histopathological characteristics of the disease. Methods …

Prostate cancer is the most commonly diagnosed malignancy in united States males.
Unfortunately, numerous controversies surround clinical management for early stage …

Prostate cancer is the most commonly diagnosed noncutaneous tumor in North American
men and confers significant morbidity and mortality to the general population. The use of …

BACKGROUND To identify associations of other cancers with hereditary prostate cancer
(HPC) we estimated relative risks (RRs) of 36 different cancers in relatives of prostate cancer …

In 2006, f234, 460 men in the US will be diagnosed with prostate cancer, and> 27,000
deaths will be attributed to the disease (1). There is substantial phenotypic variability among …

PURPOSE: A family history of prostate cancer is an important risk factor for this disease. The
clinical presentation and prognosis of familial disease remain uncertain. In this study these …

Genetic markers and the risk of developing prostate cancer. - Abstract - Europe PMC Sign in |
Create an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact …

Objectives. Prostate cancer (PCa) has a familial predisposition imparting an increased risk
of developing the disease in those with a family history. The pathologic characteristics are …

BACKGROUND Although all men age> 50 years are at an increased risk for the
development of prostate carcinoma, 2 major factors increase this risk: family history and …

BACKGROUND Currently used prognostic markers are limited in their ability to accurately
predict disease progression among patients with localized prostate cancer. We examined 23 …